Cargando…

Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi’s Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya

PURPOSE: Kaposi’s sarcoma (KS) is a spindle cell tumor resulting from growth dysregulation in the setting of infection with human herpes virus-8 (also called KS herpes virus). Advanced KS is characterized by poor responses to antiretroviral therapy and some of the chemotherapy readily accessible to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Busakhala, Naftali W., Waako, Paul J., Strother, Matthew Robert, Keter, Alfred Kipyegon, Kigen, Gabriel Kimutai, Asirwa, Fredrick Chite, Loehrer, Patrick J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2018
Materias:	Original Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223418/ https://www.ncbi.nlm.nih.gov/pubmed/30241150 http://dx.doi.org/10.1200/JGO.17.00077

Ejemplares similares

Three year survival among patients with aids-related Kaposi sarcoma treated with chemotherapy and combination antiretroviral therapy at Moi teaching and referral hospital, Kenya
por: Busakhala, Naftali, et al.
Publicado: (2019)

Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report
por: Kigen, Gabriel, et al.
Publicado: (2015)

Screening by Clinical Breast Examination in Western Kenya: Who Comes?
por: Busakhala, Naftali Wisindi, et al.
Publicado: (2016)

Mentoring future Kenyan oncology researchers
por: Moormann, Ann, et al.
Publicado: (2013)

Factors Associated with Uptake of Visual Inspection with Acetic Acid (VIA) for Cervical Cancer Screening in Western Kenya
por: Orang’o, Elkanah Omenge, et al.
Publicado: (2016)

Real-world use of chemotherapy for Kaposi’s sarcoma in a large community-based HIV primary care system in Kenya
por: Freeman, Esther E., et al.
Publicado: (2020)

Integration of Palliative Care Into Comprehensive Cancer Treatment at Moi Teaching and Referral Hospital in Western Kenya
por: Cornetta, Kenneth, et al.
Publicado: (2015)

Randomized controlled trial to evaluate locally sourced two-component compression bandages for HIV-associated Kaposi sarcoma leg lymphedema in western Kenya: The Kenyan Improvised Compression for Kaposi Sarcoma (KICKS) study protocol
por: Chang, Aileen Y., et al.
Publicado: (2018)

Treatment Outcomes of AIDS-Associated Kaposi's Sarcoma under a Routine Antiretroviral Therapy Program in Lilongwe, Malawi: Bleomycin/Vincristine Compared to Vincristine Monotherapy
por: Mwafongo, Albert A., et al.
Publicado: (2014)

Factors associated with the high prevalence of oesophageal cancer in Western Kenya: a review
por: Kigen, Gabriel, et al.
Publicado: (2017)

Refining a questionnaire to assess breast cancer knowledge and barriers to screening in Kenya: Psychometric assessment of the BCAM
por: Wachira, J., et al.
Publicado: (2017)

A Review of the Ingredients Contained in Over the Counter (OTC) Cough Syrup Formulations in Kenya. Are They Harmful to Infants?
por: Kigen, Gabriel, et al.
Publicado: (2015)

Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa
por: Semeere, Aggrey, et al.
Publicado: (2017)

Developing Palliative Medicine as an Accredited Medical Specialty in Kenya
por: Elias, Hussein, et al.
Publicado: (2022)

Enhancing Healthcare Workers’ Capacity in Cancer and Other Non-Communicable Diseases (NCDs) Care in Sub-Saharan Africa (SSA) Through e-Health Innovations: A Case of International Cancer Institute (ICI), Eldoret, Kenya
por: Kitur, Gloria, et al.
Publicado: (2022)

Addressing the Barrier of Physical Access to Oncology Care in Sub-Saharan Africa (SSA) Through Establishment of Short-Stay Homes for Cancer Patients: A Case of International Cancer Institute, Child and Family Wellness Center in Eldoret, Kenya
por: Kitur, Gloria, et al.
Publicado: (2022)

Risk of Bleeding Associated With Outpatient Use of Rivaroxaban in VTE Management at a National Referral Hospital in Western Kenya
por: Njuguna, Dennis, et al.
Publicado: (2023)

Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi’s sarcoma in five countries across sub-Saharan Africa
por: Freeman, Esther, et al.
Publicado: (2016)

Building a Sustainable Comprehensive Multiple Myeloma Program in Western Kenya
por: Oduor, Mercy A., et al.
Publicado: (2021)

Barriers and facilitators to chemotherapy initiation and adherence for patients with HIV-associated Kaposi’s sarcoma in Kenya: a qualitative study
por: McMahon, Devon E., et al.
Publicado: (2022)

Telling the story of intersectional stigma in HIV‐associated Kaposi's sarcoma in western Kenya: a convergent mixed‐methods approach
por: Collier, Sigrid, et al.
Publicado: (2022)

Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats
por: HE, HUANYU, et al.
Publicado: (2015)

Phase I-II study of carboplatin vincristine methotrexate and bleomycin (COMB) in carcinoma of the cervix.
por: Rustin, G. J., et al.
Publicado: (1988)

Reflectance confocal microscopy for Kaposi's sarcoma treatment monitoring after intralesional vincristine chemotherapy
por: Villani, Alessia, et al.
Publicado: (2022)

Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study
por: El-Mallawany, Nader Kim, et al.
Publicado: (2016)

Removal of two cytostatic drugs: bleomycin and vincristine by white-rot fungi – a sorption study
por: Jureczko, Marcelina, et al.
Publicado: (2021)

Retrospective Analysis of Presentation, Treatment, and Outcomes of Multiple Myeloma at a Large Public Referral Hospital in Eldoret, Kenya
por: Manyega, Kelvin M., et al.
Publicado: (2021)

Developing medical oncology in Africa
por: Busakhala, Naftali
Publicado: (2019)

Electrochemotherapy with bleomycin as an effective local treatment for Kaposi’s sarcoma: a case report
por: Niccolò, Allievi, et al.
Publicado: (2023)

Lymph cancer chemotherapy: delivery of doxorubicin–gemcitabine prodrug and vincristine by nanostructured lipid carriers
por: Ni, Shuqin, et al.
Publicado: (2017)

Recommendations from the ASCO Academic Global Oncology Task Force
por: Gralow, Julie R., et al.
Publicado: (2020)

Compression Therapy for HIV-Associated Kaposi Sarcoma Leg Lymphedema: Results of the Kenyan Improvised Compression for Kaposi Sarcoma Randomized Controlled Trial
por: Chang, Aileen Y., et al.
Publicado: (2022)

Accuracy of Clinical Suspicion and Pathologic Diagnosis of Kaposi Sarcoma in East Africa
por: Amerson, Erin, et al.
Publicado: (2016)

Towards a unified approach for multiple myeloma care in Kenya - proceedings of the Inaugural Multiple Myeloma Congress
por: Lotodo, Teresa Cherop, et al.
Publicado: (2021)

Pulmonary Toxicity after a Quick Course of Combinatorial Vincristine, Bleomycin, and Cisplatin Neoadjuvant Chemotherapy in Cervical Cancer
por: Ki, Kyung-Do, et al.
Publicado: (2010)

Characteristics of patients with thromboembolic disorders on warfarin therapy in resource limited settings
por: Kamuren, Zipporah, et al.
Publicado: (2018)

Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)
por: Cafferty, Fay H., et al.
Publicado: (2020)

Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours
por: Anthoney, D A, et al.
Publicado: (2004)

The Feasibility and Acceptability of an mHealth Conversational Agent Designed to Support HIV Self-testing in South Africa: Cross-sectional Study
por: Ntinga, Xolani, et al.
Publicado: (2022)

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.
por: Punt, C. J., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_n2f9fkepnpatr0i447ie2vi5ij